Evidence map›Paper›PMID 40494317›Full record

ArticleThe American journal of tropical medicine and hygiene2025

Analyzing Transmission Patterns of Two Dengue Virus Serotypes during the 2023 Outbreak in Mali, West Africa.

Fousseyni Kane, Yacouba Cissoko, John Collins, Dramane Diallo, Bassirou Diarra, Amadou Kone, Djeneba K Dabitao, Oumar Sako, Tenin A Coulibaly, Daouda Keita and 19 more

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Fousseyni KaneUniversity Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Yacouba CissokoUniversity Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
John CollinsGlobal Alliance for Preventing Pandemics, Columbia University, New York, New York.
Dramane DialloUniversity Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Bassirou DiarraUniversity Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Amadou KoneUniversity Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Djeneba K DabitaoUniversity Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Oumar SakoAfrican Centre of Excellence in Bioinformatics and Data Intensive Science (ACE-B), USTTB, Bamako, Mali.
Tenin A CoulibalyUniversity Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Daouda KeitaUniversity Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Antieme Combo Georges TogoUniversity Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Gagni CoulibalyUniversity Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Cheick O TangaraUniversity Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Mahamadou DiakiteUniversity Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Issa KonateUniversity Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Xiang-Jun LuGlobal Alliance for Preventing Pandemics, Columbia University, New York, New York.
Thomas BrieseGlobal Alliance for Preventing Pandemics, Columbia University, New York, New York.
W Ian LipkinGlobal Alliance for Preventing Pandemics, Columbia University, New York, New York.
D Camila OdioViral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
C Leah KatzelnickViral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Jamila AboulhabCollaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Esther AkpaCollaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Karine Fouth-TchosCollaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Aaron T NealCollaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Kathryn Shaw-SalibaCollaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Sounkalo DaoUniversity Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Ray Y ChenCollaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
J Kenneth WickiserGlobal Alliance for Preventing Pandemics, Columbia University, New York, New York.
Seydou DoumbiaUniversity Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.

Funding

Training Program on Operational and Health Services Research for Malaria in MaliD43TW008652 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI SEYDOU DOUMBIA, Alexandre Delamou · 2010 to 2026
$3.1M
West African Center of Excellence for Global Health Bioinformatics Research TrainingU2RTW010673 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI DOUMBIA, SEYDOU, LI, JIAN · 2017 to 2021
$1.2M
Training West African Public Health and Clinical Research Professionals to Conduct Pan-Pathogen Surveillance Using Sustainable and Effective Genetic, Molecular, and Serological Approaches (TWA-PPPSA)D43TW012737 · FIC · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SEYDOU DOUMBIA, John Kenneth Wickiser · 2024 to 2026
$739k
West Africa Center of Excellence for Data Science Research EducationUE5TW012526 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI DOUMBIA, SEYDOU, SHAFFER, JEFFREY G · 2023 to 2025
$600k
FIC NIH HHS D43 TW008652FIC NIH HHS D43 TW012737FIC NIH HHS U2R TW010673FIC NIH HHS UE5 TW012526NCI NIH HHS HHSN261201500003CNCI NIH HHS HHSN261201500003I
6 · The paper itself

Abstract

Dengue fever, a vector-borne disease caused by four serotypes of dengue virus (DENV), ranges from asymptomatic to severe illness, including hemorrhagic fever and shock syndrome. A 2023 outbreak (August 2023-May 2024) in Mali affected six districts in Bamako, causing 1,422 confirmed cases with a 2.7% fatality rate. In this study, viral sequencing provided insights into the molecular epidemiology and transmission dynamics of this outbreak. From September to October 2023, 23 of 42 suspected cases detected through national dengue surveillance activities were tested using the pan-vertebrate virus metagenomics method (virome capture sequencing platform for vertebrate viruses [VirCapSeq-VERT]). Sequencing data were analyzed using the Rapid Identification of Microbes pipeline, and Bayesian phylogenetic inference with Monte Carlo methods was used to assess viral genomic evolution. Among 23 patients, 61% were male, and the median age was 37 years (range: 20-74). The most common symptoms were fever (93.1%), headache (56.5%), and asthenia (47.8%). The largest proportion experienced dengue with warning signs (65.2%), followed by dengue without warning signs (30.4%) and severe dengue (4.4%). The successful sequencing of 19 samples revealed dengue virus serotype 3 (DENV-3; genotype III) in 15 (65.21%) samples and dengue virus serotype 1 (DENV-1; genotype III) in 4 (17.39%) samples. The DENV-1 sequences were analogous to West African sequences, and the DENV-3 were clustered with West African, Asian, and Caribbean sequences. In this study of DENV in Mali, we offer insights into the molecular epidemiology of the virus and underscore the benefits of the genomic surveillance of arboviruses in West Africa.

Indexed as

DengueDengue VirusDisease OutbreaksAdultAgedFemaleHumansMaleMaliMiddle AgedPhylogenySerogroupYoung Adult

Identifiers

PMID40494317
PMCPMC12360097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.